Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Liver-on-Chip Market by Type (Liver-on-a-chip, Kidney-on-a-chip, Lung-on-a-chip, Heart-on-a-chip, Intestine-on-a-chip, Brain-on-a-chip, Other Organs.) and by Application (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Cosmetics Industry, Other End Users): Global Opportunity Analysis and Industry Forecast, 2023-2032

A04613

Pages: NA

Charts: NA

Tables: NA

 Key Market Segments

  • By Type
    • Liver-on-a-chip
    • Kidney-on-a-chip
    • Lung-on-a-chip
    • Heart-on-a-chip
    • Intestine-on-a-chip
    • Brain-on-a-chip
    • Other Organs.
  • By Application
    • Pharmaceutical and Biotechnology Companies
    • Academic and Research Institutes
    • Cosmetics Industry
    • Other End Users
  • By Geography
    • North America
      • U.S
      • Canada
    • Europe
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Rest of Asia Pacific
    • LAMEA
      • Latin America
      • Middle East
      • Africa

 
Key Market Players

  • CN Bio Innovations
  • Nortis
  • Tara Biosystems
  • TissUse
  • Hesperos
  • Micronit Microtechnologies B.V.
  • Kirkstall
  • Draper Laboratory
  • Emulate
  • Mimetas

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: LIVER-ON-CHIP MARKET, BY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Type

    • 4.2. Liver-on-a-chip

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Kidney-on-a-chip

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Lung-on-a-chip

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Heart-on-a-chip

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Intestine-on-a-chip

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

    • 4.7. Brain-on-a-chip

      • 4.7.1. Key Market Trends, Growth Factors and Opportunities

      • 4.7.2. Market Size and Forecast, By Region

      • 4.7.3. Market Share Analysis, By Country

    • 4.8. Other Organs.

      • 4.8.1. Key Market Trends, Growth Factors and Opportunities

      • 4.8.2. Market Size and Forecast, By Region

      • 4.8.3. Market Share Analysis, By Country

  • CHAPTER 5: LIVER-ON-CHIP MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Pharmaceutical And Biotechnology Companies

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Academic And Research Institutes

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Cosmetics Industry

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Other End Users

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

  • CHAPTER 6: LIVER-ON-CHIP MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Type

      • 6.2.3. Market Size and Forecast, By Application

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Liver-on-chip Market

        • 6.2.5.1. Market Size and Forecast, By Type
        • 6.2.5.2. Market Size and Forecast, By Application

      • 6.2.6. Canada Liver-on-chip Market

        • 6.2.6.1. Market Size and Forecast, By Type
        • 6.2.6.2. Market Size and Forecast, By Application

      • 6.2.7. Mexico Liver-on-chip Market

        • 6.2.7.1. Market Size and Forecast, By Type
        • 6.2.7.2. Market Size and Forecast, By Application

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Type

      • 6.3.3. Market Size and Forecast, By Application

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Liver-on-chip Market

        • 6.3.5.1. Market Size and Forecast, By Type
        • 6.3.5.2. Market Size and Forecast, By Application

      • 6.3.6. Germany Liver-on-chip Market

        • 6.3.6.1. Market Size and Forecast, By Type
        • 6.3.6.2. Market Size and Forecast, By Application

      • 6.3.7. Italy Liver-on-chip Market

        • 6.3.7.1. Market Size and Forecast, By Type
        • 6.3.7.2. Market Size and Forecast, By Application

      • 6.3.8. Spain Liver-on-chip Market

        • 6.3.8.1. Market Size and Forecast, By Type
        • 6.3.8.2. Market Size and Forecast, By Application

      • 6.3.9. UK Liver-on-chip Market

        • 6.3.9.1. Market Size and Forecast, By Type
        • 6.3.9.2. Market Size and Forecast, By Application

      • 6.3.10. Russia Liver-on-chip Market

        • 6.3.10.1. Market Size and Forecast, By Type
        • 6.3.10.2. Market Size and Forecast, By Application

      • 6.3.11. Rest Of Europe Liver-on-chip Market

        • 6.3.11.1. Market Size and Forecast, By Type
        • 6.3.11.2. Market Size and Forecast, By Application

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Type

      • 6.4.3. Market Size and Forecast, By Application

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Liver-on-chip Market

        • 6.4.5.1. Market Size and Forecast, By Type
        • 6.4.5.2. Market Size and Forecast, By Application

      • 6.4.6. Japan Liver-on-chip Market

        • 6.4.6.1. Market Size and Forecast, By Type
        • 6.4.6.2. Market Size and Forecast, By Application

      • 6.4.7. India Liver-on-chip Market

        • 6.4.7.1. Market Size and Forecast, By Type
        • 6.4.7.2. Market Size and Forecast, By Application

      • 6.4.8. South Korea Liver-on-chip Market

        • 6.4.8.1. Market Size and Forecast, By Type
        • 6.4.8.2. Market Size and Forecast, By Application

      • 6.4.9. Australia Liver-on-chip Market

        • 6.4.9.1. Market Size and Forecast, By Type
        • 6.4.9.2. Market Size and Forecast, By Application

      • 6.4.10. Thailand Liver-on-chip Market

        • 6.4.10.1. Market Size and Forecast, By Type
        • 6.4.10.2. Market Size and Forecast, By Application

      • 6.4.11. Malaysia Liver-on-chip Market

        • 6.4.11.1. Market Size and Forecast, By Type
        • 6.4.11.2. Market Size and Forecast, By Application

      • 6.4.12. Indonesia Liver-on-chip Market

        • 6.4.12.1. Market Size and Forecast, By Type
        • 6.4.12.2. Market Size and Forecast, By Application

      • 6.4.13. Rest of Asia Pacific Liver-on-chip Market

        • 6.4.13.1. Market Size and Forecast, By Type
        • 6.4.13.2. Market Size and Forecast, By Application

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Type

      • 6.5.3. Market Size and Forecast, By Application

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Liver-on-chip Market

        • 6.5.5.1. Market Size and Forecast, By Type
        • 6.5.5.2. Market Size and Forecast, By Application

      • 6.5.6. South Africa Liver-on-chip Market

        • 6.5.6.1. Market Size and Forecast, By Type
        • 6.5.6.2. Market Size and Forecast, By Application

      • 6.5.7. Saudi Arabia Liver-on-chip Market

        • 6.5.7.1. Market Size and Forecast, By Type
        • 6.5.7.2. Market Size and Forecast, By Application

      • 6.5.8. UAE Liver-on-chip Market

        • 6.5.8.1. Market Size and Forecast, By Type
        • 6.5.8.2. Market Size and Forecast, By Application

      • 6.5.9. Argentina Liver-on-chip Market

        • 6.5.9.1. Market Size and Forecast, By Type
        • 6.5.9.2. Market Size and Forecast, By Application

      • 6.5.10. Rest of LAMEA Liver-on-chip Market

        • 6.5.10.1. Market Size and Forecast, By Type
        • 6.5.10.2. Market Size and Forecast, By Application

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Emulate

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. TissUse

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Hesperos

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. CN Bio Innovations

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Tara Biosystems

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Draper Laboratory

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Mimetas

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Nortis

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Micronit Microtechnologies B.V.

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Kirkstall

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL LIVER-ON-CHIP MARKET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL LIVER-ON-CHIP MARKET FOR LIVER-ON-A-CHIP, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL LIVER-ON-CHIP MARKET FOR KIDNEY-ON-A-CHIP, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL LIVER-ON-CHIP MARKET FOR LUNG-ON-A-CHIP, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL LIVER-ON-CHIP MARKET FOR HEART-ON-A-CHIP, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL LIVER-ON-CHIP MARKET FOR INTESTINE-ON-A-CHIP, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL LIVER-ON-CHIP MARKET FOR BRAIN-ON-A-CHIP, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL LIVER-ON-CHIP MARKET FOR OTHER ORGANS., BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL LIVER-ON-CHIP MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL LIVER-ON-CHIP MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL LIVER-ON-CHIP MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL LIVER-ON-CHIP MARKET FOR COSMETICS INDUSTRY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL LIVER-ON-CHIP MARKET FOR OTHER END USERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL LIVER-ON-CHIP MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. NORTH AMERICA LIVER-ON-CHIP, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. NORTH AMERICA LIVER-ON-CHIP, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 17. NORTH AMERICA LIVER-ON-CHIP, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 18. U.S. LIVER-ON-CHIP, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 19. U.S. LIVER-ON-CHIP, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 20. CANADA LIVER-ON-CHIP, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 21. CANADA LIVER-ON-CHIP, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 22. MEXICO LIVER-ON-CHIP, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 23. MEXICO LIVER-ON-CHIP, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 24. EUROPE LIVER-ON-CHIP, BY REGION, 2025-2033 ($MILLION)
  • TABLE 25. EUROPE LIVER-ON-CHIP, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 26. EUROPE LIVER-ON-CHIP, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 27. FRANCE LIVER-ON-CHIP, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 28. FRANCE LIVER-ON-CHIP, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 29. GERMANY LIVER-ON-CHIP, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 30. GERMANY LIVER-ON-CHIP, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 31. ITALY LIVER-ON-CHIP, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 32. ITALY LIVER-ON-CHIP, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 33. SPAIN LIVER-ON-CHIP, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 34. SPAIN LIVER-ON-CHIP, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 35. UK LIVER-ON-CHIP, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 36. UK LIVER-ON-CHIP, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 37. RUSSIA LIVER-ON-CHIP, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 38. RUSSIA LIVER-ON-CHIP, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 39. REST OF EUROPE LIVER-ON-CHIP, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 40. REST OF EUROPE LIVER-ON-CHIP, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 41. ASIA-PACIFIC LIVER-ON-CHIP, BY REGION, 2025-2033 ($MILLION)
  • TABLE 42. ASIA-PACIFIC LIVER-ON-CHIP, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 43. ASIA-PACIFIC LIVER-ON-CHIP, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 44. CHINA LIVER-ON-CHIP, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 45. CHINA LIVER-ON-CHIP, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 46. JAPAN LIVER-ON-CHIP, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 47. JAPAN LIVER-ON-CHIP, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 48. INDIA LIVER-ON-CHIP, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 49. INDIA LIVER-ON-CHIP, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 50. SOUTH KOREA LIVER-ON-CHIP, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 51. SOUTH KOREA LIVER-ON-CHIP, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 52. AUSTRALIA LIVER-ON-CHIP, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 53. AUSTRALIA LIVER-ON-CHIP, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 54. THAILAND LIVER-ON-CHIP, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 55. THAILAND LIVER-ON-CHIP, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 56. MALAYSIA LIVER-ON-CHIP, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 57. MALAYSIA LIVER-ON-CHIP, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 58. INDONESIA LIVER-ON-CHIP, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 59. INDONESIA LIVER-ON-CHIP, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 60. REST OF ASIA PACIFIC LIVER-ON-CHIP, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 61. REST OF ASIA PACIFIC LIVER-ON-CHIP, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 62. LAMEA LIVER-ON-CHIP, BY REGION, 2025-2033 ($MILLION)
  • TABLE 63. LAMEA LIVER-ON-CHIP, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 64. LAMEA LIVER-ON-CHIP, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 65. BRAZIL LIVER-ON-CHIP, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 66. BRAZIL LIVER-ON-CHIP, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 67. SOUTH AFRICA LIVER-ON-CHIP, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 68. SOUTH AFRICA LIVER-ON-CHIP, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 69. SAUDI ARABIA LIVER-ON-CHIP, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 70. SAUDI ARABIA LIVER-ON-CHIP, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 71. UAE LIVER-ON-CHIP, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 72. UAE LIVER-ON-CHIP, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 73. ARGENTINA LIVER-ON-CHIP, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 74. ARGENTINA LIVER-ON-CHIP, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 75. REST OF LAMEA LIVER-ON-CHIP, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 76. REST OF LAMEA LIVER-ON-CHIP, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 77. EMULATE: KEY EXECUTIVES
  • TABLE 78. EMULATE: COMPANY SNAPSHOT
  • TABLE 79. EMULATE: OPERATING SEGMENTS
  • TABLE 80. EMULATE: PRODUCT PORTFOLIO
  • TABLE 81. EMULATE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 82. TISSUSE: KEY EXECUTIVES
  • TABLE 83. TISSUSE: COMPANY SNAPSHOT
  • TABLE 84. TISSUSE: OPERATING SEGMENTS
  • TABLE 85. TISSUSE: PRODUCT PORTFOLIO
  • TABLE 86. TISSUSE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 87. HESPEROS: KEY EXECUTIVES
  • TABLE 88. HESPEROS: COMPANY SNAPSHOT
  • TABLE 89. HESPEROS: OPERATING SEGMENTS
  • TABLE 90. HESPEROS: PRODUCT PORTFOLIO
  • TABLE 91. HESPEROS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 92. CN BIO INNOVATIONS: KEY EXECUTIVES
  • TABLE 93. CN BIO INNOVATIONS: COMPANY SNAPSHOT
  • TABLE 94. CN BIO INNOVATIONS: OPERATING SEGMENTS
  • TABLE 95. CN BIO INNOVATIONS: PRODUCT PORTFOLIO
  • TABLE 96. CN BIO INNOVATIONS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 97. TARA BIOSYSTEMS: KEY EXECUTIVES
  • TABLE 98. TARA BIOSYSTEMS: COMPANY SNAPSHOT
  • TABLE 99. TARA BIOSYSTEMS: OPERATING SEGMENTS
  • TABLE 100. TARA BIOSYSTEMS: PRODUCT PORTFOLIO
  • TABLE 101. TARA BIOSYSTEMS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 102. DRAPER LABORATORY: KEY EXECUTIVES
  • TABLE 103. DRAPER LABORATORY: COMPANY SNAPSHOT
  • TABLE 104. DRAPER LABORATORY: OPERATING SEGMENTS
  • TABLE 105. DRAPER LABORATORY: PRODUCT PORTFOLIO
  • TABLE 106. DRAPER LABORATORY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 107. MIMETAS: KEY EXECUTIVES
  • TABLE 108. MIMETAS: COMPANY SNAPSHOT
  • TABLE 109. MIMETAS: OPERATING SEGMENTS
  • TABLE 110. MIMETAS: PRODUCT PORTFOLIO
  • TABLE 111. MIMETAS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 112. NORTIS: KEY EXECUTIVES
  • TABLE 113. NORTIS: COMPANY SNAPSHOT
  • TABLE 114. NORTIS: OPERATING SEGMENTS
  • TABLE 115. NORTIS: PRODUCT PORTFOLIO
  • TABLE 116. NORTIS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 117. MICRONIT MICROTECHNOLOGIES B.V.: KEY EXECUTIVES
  • TABLE 118. MICRONIT MICROTECHNOLOGIES B.V.: COMPANY SNAPSHOT
  • TABLE 119. MICRONIT MICROTECHNOLOGIES B.V.: OPERATING SEGMENTS
  • TABLE 120. MICRONIT MICROTECHNOLOGIES B.V.: PRODUCT PORTFOLIO
  • TABLE 121. MICRONIT MICROTECHNOLOGIES B.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 122. KIRKSTALL: KEY EXECUTIVES
  • TABLE 123. KIRKSTALL: COMPANY SNAPSHOT
  • TABLE 124. KIRKSTALL: OPERATING SEGMENTS
  • TABLE 125. KIRKSTALL: PRODUCT PORTFOLIO
  • TABLE 126. KIRKSTALL: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL LIVER-ON-CHIP MARKET SEGMENTATION
  • FIGURE 2. GLOBAL LIVER-ON-CHIP MARKET
  • FIGURE 3. SEGMENTATION LIVER-ON-CHIP MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN LIVER-ON-CHIP MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALLIVER-ON-CHIP MARKET
  • FIGURE 11. LIVER-ON-CHIP MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 12. LIVER-ON-CHIP MARKET FOR LIVER-ON-A-CHIP, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. LIVER-ON-CHIP MARKET FOR KIDNEY-ON-A-CHIP, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. LIVER-ON-CHIP MARKET FOR LUNG-ON-A-CHIP, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. LIVER-ON-CHIP MARKET FOR HEART-ON-A-CHIP, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. LIVER-ON-CHIP MARKET FOR INTESTINE-ON-A-CHIP, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. LIVER-ON-CHIP MARKET FOR BRAIN-ON-A-CHIP, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. LIVER-ON-CHIP MARKET FOR OTHER ORGANS., BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. LIVER-ON-CHIP MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 20. LIVER-ON-CHIP MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. LIVER-ON-CHIP MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. LIVER-ON-CHIP MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. LIVER-ON-CHIP MARKET FOR OTHER END USERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 24. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 25. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 26. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 27. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 28. COMPETITIVE DASHBOARD
  • FIGURE 29. COMPETITIVE HEATMAP: LIVER-ON-CHIP MARKET
  • FIGURE 30. TOP PLAYER POSITIONING, 2024
  • FIGURE 31. EMULATE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 32. EMULATE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 33. EMULATE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 34. TISSUSE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 35. TISSUSE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 36. TISSUSE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 37. HESPEROS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 38. HESPEROS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 39. HESPEROS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 40. CN BIO INNOVATIONS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 41. CN BIO INNOVATIONS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 42. CN BIO INNOVATIONS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 43. TARA BIOSYSTEMS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 44. TARA BIOSYSTEMS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 45. TARA BIOSYSTEMS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 46. DRAPER LABORATORY: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 47. DRAPER LABORATORY: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 48. DRAPER LABORATORY: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 49. MIMETAS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 50. MIMETAS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 51. MIMETAS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 52. NORTIS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 53. NORTIS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 54. NORTIS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 55. MICRONIT MICROTECHNOLOGIES B.V.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 56. MICRONIT MICROTECHNOLOGIES B.V.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 57. MICRONIT MICROTECHNOLOGIES B.V.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 58. KIRKSTALL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 59. KIRKSTALL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 60. KIRKSTALL: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Liver-on-Chip Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved